Some quarters are all about big headlines. Others, like this one for Hyundai Motors, are about quiet confidence—solid delivery, calm navigation through headwinds, and a clear focus on where the journey leads next.

Let’s talk about Eureka Forbes Limited (EFL)—you know, the company that probably sold you your first water purifier. Well, they’re not just keeping homes clean anymore—they’re also keeping investors smiling with another impressive financial quarter.

Global Health (Medanta) continues to inspire confidence as it delivers a strong show in Q4FY25. The hospital chain has seen commendable results across both mature and new facilities, setting the tone for growth over the coming years.

Discover what’s driving the rise of India’s toy industry and key trends in the market.

If you’ve been keeping an eye on Piramal Pharma, here’s a quick lowdown on how they performed in Q4FY25 and what it means going forward.

Page Industries (PAG) reported its Q4FY25 earnings with some encouraging numbers — but inflation and valuation concerns keep the recommendation unchanged: SELL. Here’s a simple breakdown.

JSW Energy released its results for Q4FY25, showing steady growth, largely helped by its recent KSK acquisition. However, earnings remain under pressure, and the stock’s valuation is still on the higher side. Let’s take a closer look.

A silent revolution is sweeping through India’s Tier 2 and 3 cities. From booming SIPs to IPO-savvy investors, Bharat is no longer a passive player in India’s markets. With digital access, government support, and financial literacy rising, this blog explores how small-town India is changing how the country invests.

For years, India’s financial markets have been shaped by a complex web of regulations, especially when it comes to foreign investment. The Reserve Bank of India (RBI), ever cautious, has traditionally imposed limits on how much Foreign Portfolio Investors (FPIs) could own in various asset classes.

The hospital sector saw a healthy heartbeat in Q4, and KIMS (Krishna Institute of Medical Sciences) wrapped up the fiscal year with strength. The scalpel is sharp, and the growth trajectory looks even sharper.